Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Experts: Molecular Tests Could Improve Antibiotic Clinical Trials

This article was originally published in The Gray Sheet

Executive Summary

Greater acceptance of molecular tests that can identify rare and drug-resistant bacterial strains through their genetic material could transform antibiotics clinical trial design and lower the cost of developing new drugs, scientists said at a workshop on antibiotic drug resistance last week
Advertisement

Related Content

New Diagnostics Address Foodborne Illness Outbreaks
New Diagnostics Address Foodborne Illness Outbreaks
Regulatory News In Brief
Regulatory News In Brief

Topics

Advertisement
UsernamePublicRestriction

Register

MT029192

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel